Platform development for target identification in high risk pediatric leukemias |
Columbia University / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD |
Crazy 8 Pilots |
2019 |
New York |
Using Splice Switching Oligonucleotides (SSOs) to target MDM2 for rhabdomyosarcoma therapy |
Research Institute at Nationwide Children's Hospital / Dawn Chandler, PhD |
Innovation Grants |
2019 |
Ohio |
Therapeutic Targeting of the Disrupted Metabolic State in DIPG |
University of Michigan / Costas Lyssiotis, PhD & Sriram Venneti, MD/PhD |
Innovation Grants |
2019 |
Michigan |
Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma |
City of Hope National Medical Center / Linda Malkas, PhD |
Reach Grants |
2019 |
California |
Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs |
University of Alberta / Hasan Uludag, PhD |
Innovation Grants |
2019 |
Alberta |
Role of the macro lncRNA KCNQ1OT1 in embryonal rhabdomyosarcoma tumorigenesis |
Duke University / Corinne Linardic, MD/PhD |
Innovation Grants |
2019 |
North Carolina |
MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis |
Stanford University / Feng Pan, PhD |
Young Investigator Grants |
2019 |
California |
Generation of CMV-specific CD19 CAR T cells Using Cytokine Capture Followed by Lentiviral Transduction and Expansion |
Research Institute at Nationwide Children's Hospital / Margaret Lamb, MD |
Reach Grants |
2019 |
Ohio |
Intervention Development and Evaluation to Reduce Disparities in Quality of Life for Latino Families Impacted by Cancer |
The Regents of the University of California, Irvine / Michelle Fortier, PhD |
Psychosocial Family Impact Grant |
2019 |
California |
Epigenetic regulation of genomic instability and its therapeutic implications in T-cell acute lymphoblastic leukemia |
Dana-Farber Cancer Institute / Birgit Knoechel, MD/PhD |
Innovation Grants |
2019 |
Massachusetts |